| 000 | 01754 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515072638.0 | ||
| 264 | 0 | _c20071106 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a0090-3493 | ||
| 024 | 7 |
_a10.1097/01.CCM.0000277038.11630.71 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaas, Renke | |
| 245 | 0 | 0 |
_aElevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery. _h[electronic resource] |
| 260 |
_bCritical care medicine _cAug 2007 |
||
| 300 |
_a1876-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPerioperative Care |
| 650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSurgical Procedures, Operative |
| 700 | 1 | _aDentz, Lena | |
| 700 | 1 | _aSchwedhelm, Edzard | |
| 700 | 1 | _aThoms, Wolfgang | |
| 700 | 1 | _aKuss, Oliver | |
| 700 | 1 | _aHiltmeyer, Natascha | |
| 700 | 1 | _aHaddad, Munif | |
| 700 | 1 | _aKlöss, Thomas | |
| 700 | 1 | _aStandl, Thomas | |
| 700 | 1 | _aBöger, Rainer H | |
| 773 | 0 |
_tCritical care medicine _gvol. 35 _gno. 8 _gp. 1876-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.CCM.0000277038.11630.71 _zAvailable from publisher's website |
| 999 |
_c17118993 _d17118993 |
||